## APD: Air Products and Chemicals, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -0.2% below STRENGTH zone (3.0-6.0%); PEG 6.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($235.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bearish (Bullish: 0, Bearish: 3)

**1. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products And Chemicals, Inc. - APD**
- Source: Fox 59 | 20251224T220804 | Somewhat-Bearish | Relevance: 100%
- Pomerantz LLP is investigating potential securities fraud claims against Air Products and Chemicals, Inc. (APD). This follows a significant drop in Air Products' stock price after the company announced advanced negotiations with Yara International for a hydrogen production and ammonia combination. Investors who have suffered losses are encouraged to contact the law firm.

**2. Griffin Asset Management Inc. Sells 4,375 Shares of Air Products and Chemicals, Inc. $APD**
- Source: MarketBeat | 20251227T130956 | Neutral | Relevance: 100%
- Griffin Asset Management Inc. reduced its stake in Air Products and Chemicals (NYSE: APD) by 11.1% in Q3 2025, selling 4,375 shares and retaining 34,892 shares valued at $9.516 million. Analyst ratings are mixed with a consensus "Hold" and a target price of $292.47. The company announced a quarterly dividend of $1.79 per share, payable February 9th, with an annualized yield of 2.9%.

**3. Air Products and Chemicals, Inc. $APD Shares Sold by Meyer Handelman Co.**
- Source: MarketBeat | 20251227T124043 | Neutral | Relevance: 100%
- Meyer Handelman Co. significantly reduced its holding in Air Products and Chemicals, Inc. (NYSE:APD) by 17.1%, selling 5,425 shares and retaining 26,308 shares valued at approximately $7.175 million. This divestment comes as Air Products reported solid quarterly EPS of $3.39, exceeding estimates, and issued optimistic FY2026 guidance. The company also declared a quarterly dividend of $1.79, offering a yield of about 2.9%.

**4. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD**
- Source: www.nbc4i.com | 20251226T190759 | Bearish | Relevance: 100%
- Pomerantz LLP is investigating potential securities fraud claims against Air Products and Chemicals, Inc. (NYSE:APD) following a significant drop in its stock price. This investigation comes after Air Products announced advanced negotiations with Yara International, which led to a 9.45% decline in Air Products' share price on December 8, 2025. Investors are encouraged to contact Pomerantz LLP to learn more about joining the class action.

**5. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD**
- Source: WATE 6 On Your Side | 20251226T080726 | Bearish | Relevance: 100%
- Pomerantz LLP is investigating potential securities fraud claims against Air Products and Chemicals, Inc. (NYSE:APD). This investigation follows a significant drop in Air Products' stock price after the company announced advanced negotiations with Yara International, which raised concerns about potential unlawful business practices or securities fraud. Investors are encouraged to contact Pomerantz LLP for more information regarding the class action.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $250 | $330 | -24% |
| 2025-12-18 | Mizuho | $290 | $300 | -3% |
| 2025-12-15 | Citigroup | $245 | $300 | -18% |
| 2025-12-12 | UBS | $250 | $310 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | down | Equal-Weight |
| 2025-12-18 | Mizuho | main | Outperform |
| 2025-12-15 | Citigroup | down | Neutral |
| 2025-12-12 | UBS | down | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 22 ($0.12M) |
| Sells | 3 ($0.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+1.2%)
- Blackrock Inc.: 7.9% (-0.1%)
- JPMORGAN CHASE & CO: 5.9% (+103.2%)
- State Farm Mutual Au: 5.3% (-1.3%)
- Capital Research Glo: 5.3% (+2.4%)

### Key Risks

1. Valuation stretched: PEG 6.7x requires aggressive growth execution.
2. Long-term trend broken: trading 9.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.69 signals overvaluation risk, limited margin of safety. Forward P/E 17.9x stretched relative to 7% growth. Analyst sentiment negative (5 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $55.1B |
| Beta | 0.86 |
| 52W Range | $229.11 - $341.14 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.69 |
| Forward P/E | 17.9 |
| Current P/E | 19.2 |
| YoY Growth | 7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.2% (minimal 5-day change). Below STRENGTH zone by 3.2pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.8%) - potential reversal signal. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (0.56), confirming momentum. RSI neutral at 49. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.17% (CS: 70) | Neutral |
| RSI_14 | 48.9 | Neutral |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 0.903x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $247.47
- **Stop Loss:** $235.81 (4.7% risk)
- **Target:** $259.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $27,964.11
- **Portfolio %:** 27.96%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-05 (Est: $3.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.38 | $3.39 | +0.2% |
| 2025Q2 | $2.99 | $3.09 | +3.2% |
| 2025Q1 | $2.83 | $2.69 | -4.9% |
| 2024Q4 | $2.84 | $2.86 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*